Liver retransplantation in adults: overall results and determinant factors affecting the outcome.
作者信息
Morel P, Rilo H L, Tzakis A G, Todo S, Gordon R D, Starzl T E
机构信息
Transplant Institute, University of Pittsburgh School of Medicine, PA 15213.
出版信息
Transplant Proc. 1991 Dec;23(6):3029-31.
Abstract
摘要
相似文献
1
Liver retransplantation in adults: overall results and determinant factors affecting the outcome.成人肝脏再次移植：总体结果及影响预后的决定因素
Transplant Proc. 1991 Dec;23(6):3029-31.
2
3
Renal function in primary liver transplant recipients receiving neoral (cyclosporine) versus prograf (tacrolimus).
Transplant Proc. 1998 Jun;30(4):1401-2. doi: 10.1016/s0041-1345(98)00289-9.
4
Combined orthotopic liver-small bowel transplantation or small bowel transplantation in pigs: relations between survival, rejection, and mucosal morphometry.
Transplant Proc. 1997 May;29(3):1840-1. doi: 10.1016/s0041-1345(97)00091-2.
5
Recurrent rejection following FK 506 rescue therapy for acute hepatic allograft rejection.FK506 挽救治疗急性肝移植排斥反应后出现反复排斥反应。
Transplant Proc. 1993 Apr;25(2):1988-9.
6
Retransplantation for recurrent hepatitis C following tacrolimus or cyclosporine immunosuppression.
Transplant Proc. 1998 Jun;30(4):1470-1. doi: 10.1016/s0041-1345(98)00320-0.
7
FK 506 versus cyclosporine in pediatric liver transplantation.儿童肝移植中FK506与环孢素的比较
Transplant Proc. 1991 Dec;23(6):3010-5.
8
Use of FK506 as primary or rescue therapy after liver transplantation in Hong Kong.在香港，FK506在肝移植后作为初始治疗或挽救治疗的应用。
Transplant Proc. 1998 Nov;30(7):3587-8. doi: 10.1016/s0041-1345(98)01147-6.
9
Immunosuppression with calcineurin inhibitors and polyclonal antibodies in liver transplantation.肝移植中使用钙调神经磷酸酶抑制剂和多克隆抗体进行免疫抑制。
Transplant Proc. 2002 Feb;34(1):107. doi: 10.1016/s0041-1345(01)02690-2.
10
FK 506 rescue therapy: the rapidity of rejection reversal is related to the subsequent development of CMV disease.FK506挽救治疗：排斥反应逆转的速度与随后巨细胞病毒疾病的发生有关。
Transplant Proc. 1993 Apr;25(2):1992-3.
引用本文的文献
1
Factors affecting survival after liver retransplantation: a systematic review and meta-analysis.影响肝脏再次移植术后生存的因素：一项系统评价和荟萃分析。
Front Transplant. 2023 May 31;2:1181770. doi: 10.3389/frtra.2023.1181770. eCollection 2023.
2
Liver Re-transplantation in Adults: Indications and Outcomes Analysis of a 23-year Experience in a Single Center in Argentina.成人肝脏再次移植：阿根廷单中心23年经验的适应证与结局分析
Int J Organ Transplant Med. 2022;13(2):30-35.
3
Excellent Contemporary Graft Survival for Adult Liver Retransplantation: An Australian and New Zealand Registry Analysis From 1986 to 2017.成人肝脏再次移植的当代出色移植物存活率：1986年至2017年澳大利亚和新西兰登记处分析
Transplant Direct. 2019 Jul 23;5(8):e472. doi: 10.1097/TXD.0000000000000920. eCollection 2019 Aug.
4
Can we direct organ allocation based on predicted outcome? Hepatocellular carcinoma outside of UCSF criteria or retransplant?我们能否根据预测结果来指导器官分配？UCSF 标准之外的肝细胞癌或再次移植？
Langenbecks Arch Surg. 2012 Jun;397(5):711-5. doi: 10.1007/s00423-012-0910-3. Epub 2012 Jan 28.
5
Decision for retransplantation of the liver: an experience- and cost-based analysis.肝脏再次移植的决策：基于经验和成本的分析
Ann Surg. 2002 Dec;236(6):713-21; discussion 721. doi: 10.1097/01.SLA.0000036264.66247.65.
6
Long-term survival after retransplantation of the liver.肝脏再次移植后的长期存活情况。
Ann Surg. 1997 Oct;226(4):408-18; discussion 418-20. doi: 10.1097/00000658-199710000-00002.
7
Hepatic Retransplantation--an analysis of risk factors associated with outcome.肝再次移植——与预后相关的危险因素分析
Transplantation. 1996 May 27;61(10):1499-505. doi: 10.1097/00007890-199605270-00016.
8
Tacrolimus. A review of its pharmacology, and therapeutic potential in hepatic and renal transplantation.他克莫司。其药理学及在肝移植和肾移植中的治疗潜力综述。
Drugs. 1993 Oct;46(4):746-94. doi: 10.2165/00003495-199346040-00009.
本文引用的文献
1
Results of biliary reconstruction after liver transplantation.
Transplant Proc. 1984 Oct;16(5):1225-7.
2
Retransplantation of the liver.肝脏再次移植
Semin Liver Dis. 1985 Nov;5(4):394-401. doi: 10.1055/s-2008-1040638.
3
Variables influencing the outcome following orthotopic liver transplantation.影响原位肝移植术后结局的因素。
Arch Surg. 1987 Oct;122(10):1109-11. doi: 10.1001/archsurg.1987.01400220019001.
4
Effect of OKT3 on survival and rate of retransplantation.OKT3对生存率及再次移植率的影响。
Transplant Proc. 1987 Aug;19(4 Suppl 3):61-2.
5
Improved results with retransplantation of the liver.肝脏再次移植取得了更好的效果。
Transplant Proc. 1989 Feb;21(1 Pt 2):2407-8.
6
Liver transplantation: an unfinished product.肝移植：一项未完成的成果。
Transplant Proc. 1989 Feb;21(1 Pt 2):2197-200.
7
Results after liver retransplantation (RETx): a comparative study between "elective" vs "nonelective" RETx.肝脏再次移植（RETx）后的结果：“择期”与“非择期”再次移植的比较研究。
Transplant Proc. 1990 Aug;22(4):1509-11.
Zotero 插件